will produce vaccine for this stockpile at its manufacturing facilities in Italy.
Bradley's role in the research, and shows how Chiron
systematically diminished his role in the discovery in order to claim a monopoly in the marketplace.
was newly found there was no halo," Gehrels says.
delivers innovative and valuable products to protect human health by advancing pioneering science across the landscape of biotechnology.
We are delighted to expand our presence in Italy's growing life science market with these two latest deals with Chiron
and Axxam," said LION bioscience vice president for Global Sales Jason Theodosiou.
Under terms of this new agreement, Searle and Chiron
will grant to each other licenses to patents that lead to products within the field of the collaboration.
The researchers note that Chiron
appears about 112 miles in diameter, 10 to 20 times the size of Comet Halley.
Both CAM North America and ValueAct Capital have informed Chiron
and Novartis that they and their affiliated entities intend to vote in favor of the transaction, subject to the fiduciary and legal obligations applicable to them.
Proxy Governance, an independent proxy advisory firm, has recommended that Chiron
shareholders vote in favor of the acquisition, while Institutional Shareholder Services, another independent proxy advisory firm, has recommended voting against the acquisition.
In a letter to Howard Pien, chief executive officer of Chiron
, responding to Mr.
In the letter, ValueAct Capital also stated that if Chiron
CEO Howard Pien allowed himself to be co-opted into participating in the investor roadshow being mounted by Novartis and Chiron
's independent directors to solicit support for the $45 merger offer, despite its gross inadequacy and despite the opposition of a significant number of Chiron
's minority shareholders, ValueAct would deem such participation as a betrayal of the company's shareholders and would seek his removal as CEO if Chiron
is ultimately not sold to Novartis.
Our independent directors and management team continue to strongly recommend the Novartis transaction and believe that it represents a full and fair price and is a superior alternative for Chiron
's public stockholders to Chiron
remaining a standalone company.
First graph, first sentence of release should read: Chiron
Corporation (NASDAQ:CHIR) today announced that it will convene a special meeting of stockholders on Wednesday, April 12, 2006, to vote to approve its proposed merger with Novartis AG (sted Tuesday, April 18, 2006).
Corporation (NASDAQ:CHIR) today announced that it has entered into a supply contract with the UK government for pre-pandemic influenza vaccine(1) for a stockpile based on the H5N1 avian influenza virus strain.
is producing this stockpile at its facility in Liverpool, England, and expects to complete approximately 70 percent of the order before turning operations to annual production of FLUVIRIN(R) influenza virus vaccine in March.